GILEAD SCIENCES, INC. - Common Stock (GILD)

Historical Holders from Q1 2014 to Q3 2025

Symbol: GILD on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 1,240,722,841
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 1,051,656,575
Holdings value: $116,752,427,923
% of all portfolios: 0.05%
Number of holders: 1,991
Number of buys: 965
Number of sells: -837
Average buys %: +0.01%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of GILEAD SCIENCES, INC. - Common Stock (GILD)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	8.2%		$10,799,623,829		101,739,273		BlackRock, Inc.	31 Mar 2025
Capital World Investors	4.3%		$5,714,571,769		53,834,873		Capital World Investors	31 Mar 2025

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	1,051,656,575	$116,752,427,923	-$2,273,237,737	$752,104,774	$885,028,546	$111	1,991
2025 Q2	1,073,254,023	$118,963,159,666	+$3,514,133,066	$945,276,027	$1,269,581,823	$110.87	2,000
2025 Q1	1,043,338,274	$116,881,227,875	-$1,852,497,281	$1,054,254,689	$1,032,439,799	$112.05	1,991
2024 Q4	1,061,928,121	$98,045,307,663	+$1,597,585,192	$837,352,010	$769,503,942	$92.37	1,868
2024 Q3	1,041,031,806	$87,292,159,028	+$497,071,935	$815,607,330	$864,801,437	$83.84	1,702
2024 Q2	1,032,141,981	$70,791,566,038	-$264,255,142	$612,865,050	$809,851,328	$68.61	1,666
2024 Q1	1,039,326,218	$76,098,429,205	-$499,202,917	$585,726,773	$626,877,914	$73.25	1,705
2023 Q4	1,044,478,354	$84,656,377,441	+$255,439,953	$763,886,928	$703,817,121	$81.01	1,763
2023 Q3	1,039,821,240	$77,974,757,522	-$75,610,588	$673,781,686	$742,403,376	$74.94	1,671
2023 Q2	1,042,887,174	$80,416,194,253	+$427,085,098	$572,441,489	$733,272,484	$77.07	1,687
2023 Q1	1,034,794,880	$85,819,040,826	+$628,903,617	$671,752,922	$759,416,549	$82.97	1,717
2022 Q4	1,031,461,660	$88,551,084,722	+$2,216,871,534	$1,009,823,353	$1,014,231,647	$85.85	1,747
2022 Q3	1,003,983,340	$61,982,373,182	+$689,958,176	$615,220,224	$812,898,870	$61.69	1,570
2022 Q2	993,379,548	$61,392,230,451	+$324,575,776	$606,509,794	$824,143,157	$61.81	1,587
2022 Q1	988,770,035	$58,777,059,567	-$957,879,872	$1,042,947,145	$1,100,688,610	$59.45	1,567
2021 Q4	1,009,356,244	$73,295,492,986	+$193,423,902	$1,763,590,409	$1,480,660,733	$72.61	1,663
2021 Q3	999,239,167	$69,763,198,043	+$691,955,339	$1,416,207,075	$1,306,666,830	$69.85	1,544
2021 Q2	989,284,689	$68,064,289,407	+$647,772,893	$1,294,174,968	$1,414,026,940	$68.86	1,524
2021 Q1	981,962,949	$63,398,921,279	+$771,179,759	$1,441,078,513	$1,555,861,034	$64.63	1,551
2020 Q4	971,052,591	$56,534,223,402	-$194,225,396	$1,496,896,832	$1,221,043,412	$58.26	1,543
2020 Q3	975,382,123	$61,581,778,990	-$1,221,202,886	$1,660,735,679	$1,193,339,705	$63.19	1,524
2020 Q2	990,066,372	$76,108,860,118	-$470,860,186	$1,809,624,000	$1,527,539,000	$76.94	1,618
2020 Q1	998,079,792	$74,600,178,391	-$1,145,482,309	$1,695,350,000	$2,036,308,000	$74.76	1,633
2019 Q4	1,013,882,391	$65,874,525,082	+$31,658,674	$1,247,196,000	$1,259,439,000	$64.98	1,547
2019 Q3	1,013,158,831	$64,205,170,698	-$201,708,522	$959,445,000	$651,826,000	$63.38	1,452
2019 Q2	1,017,131,311	$68,703,708,929	+$1,159,368,401	$900,646,000	$738,353,000	$67.56	1,472
2019 Q1	1,015,569,209	$66,012,744,686	-$243,978,731	$930,522,000	$686,379,000	$65.01	1,476
2018 Q4	1,019,661,172	$63,734,090,725	+$29,422,887	$1,136,536,000	$807,354,000	$62.55	1,478
2018 Q3	1,022,396,822	$78,869,235,633	+$2,219,917,371	$1,405,134,000	$962,014,000	$77.21	1,520
2018 Q2	992,982,498	$70,297,342,536	-$2,364,209,399	$1,573,314,000	$930,835,000	$70.84	1,516
2018 Q1	1,024,922,600	$77,180,332,612	+$357,307,777	$1,772,930,934	$1,556,051,099	$75.39	1,558
2017 Q4	1,022,247,620	$73,179,775,286	+$1,023,841,433	$2,387,576,828	$1,484,790,748	$71.64	1,574
2017 Q3	1,004,542,606	$81,371,526,834	+$2,310,126,305	$2,353,813,000	$1,676,551,000	$81.02	1,501
2017 Q2	978,374,690	$69,232,836,215	+$313,533,710	$2,095,949,000	$1,569,515,000	$70.78	1,514
2017 Q1	975,372,838	$66,220,816,545	+$5,353,818,575	$2,020,140,000	$1,286,836,000	$67.92	1,515
2016 Q4	991,376,626	$70,992,715,949	-$496,869,443	$1,868,992,000	$1,690,113,000	$71.61	1,565
2016 Q3	994,641,139	$78,638,414,793	-$3,545,904,859	$2,239,501,000	$1,913,099,700	$79.12	1,547
2016 Q2	1,039,317,614	$86,682,066,843	-$2,513,064,923	$1,679,026,000	$1,157,778,000	$83.42	1,587
2016 Q1	1,068,034,773	$98,100,074,299	-$6,517,835,276	$1,601,746,000	$1,413,670,000	$91.86	1,617
2015 Q4	1,137,355,202	$115,088,592,819	-$3,128,093,783	$2,415,183,000	$1,864,171,000	$101.19	1,621
2015 Q3	1,164,695,259	$114,359,980,167	-$3,451,464,869	$2,807,873,000	$1,795,374,000	$98.19	1,561
2015 Q2	1,199,337,377	$140,402,300,771	-$4,005,236,404	$3,183,694,000	$1,785,068,000	$117.08	1,549
2015 Q1	1,234,393,342	$121,177,956,582	-$2,154,329,861	$3,356,288,000	$2,195,449,000	$98.13	1,481
2014 Q4	1,258,378,649	$118,685,414,349	-$4,388,207,356	$4,063,976,000	$2,858,586,000	$94.26	1,426
2014 Q3	1,293,869,876	$137,734,928,602	-$9,497,208,855	$3,472,613,000	$2,256,698,000	$106.45	1,315
2014 Q2	1,377,947,628	$114,268,245,236	-$1,971,113,663	$2,273,244,000	$1,837,523,000	$82.91	1,253
2014 Q1	1,405,078,310	$99,582,400,406	-$880,737,639	$2,128,829,000	$1,115,156,000	$70.86	1,177